#In Situ Hybridization (ISH) Market Size

[marketingreportz]

Companion Diagnostics Market - Forecast(2024 - 2030)

 Companion Diagnostic Market Overview:

The Harvard University, while addressing the risk associated with reactions of new drugs prescription, has stated some overwhelming facts. According to their findings, even properly prescribed drugs causes about 1.9 million hospitalizations a year and about 128,000 people die from drugs prescribed to them.[1] Such epidemic condition is being tailgated by the need of safe and effective and specific use of the drug. Owing to such demands, companion diagnostic drug market is poised for exponential growth. Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients and is crucial for myriad of cancer and other therapies. Riding on the back of economic burden of global healthcare and with abundant potential to restrict the liability, companion diagnostic market size is estimated to be $2,950 million as of 2018.

Inquiry Before Buying

Companion Diagnostic Market Outlook:

Companion diagnostic (CDx) is a diagnostic test used as an associate to a therapeutic drug to regulate its applicability to an individual person. It involves multiple monitoring methods including immunohistochemistry (IHC), polymerase chain Reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), and gene sequencing. The companion diagnostics uses technologies such as molecular biology technique, drug and diagnostic technology, and oncology therapy for the treatment of colorectal cancer, breast cancer, and other chronic diseases.

 An acute analysis of the region-wise companion diagnostic market share concluded with reckoning North America as the most lucrative market for CDx. This region with cutting-edge healthcare technology in the United States and Canada generates 41% of the global companion diagnostic market demand for alarming need for cancer diagnosis and treatment. According to the American Cancer Society, prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers and among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common. Increasing instances of cancer along with neurological disorders, infectious diseases, Hepatitis A is augmenting the North American companion diagnostic market.

Companion diagnostic market with abundant potential as an effective tool for personalized medicine has found a tremendous scope of application in pharmaceuticals, laboratories, research institutes and hospitals. Hospital as an end-user industry is the leading segment progressing with an application CAGR of 12.5% going through 2025. Hospitalized patients account for a total of 2.74 million serious adverse drug reactions. Each CDx test is specifically designed to be corresponding with an exact drug. Such tests can also save significant hospital expenditure by targeting specific patients with the most effective therapy.

Request Sample

 Companion Diagnostic Market Trends and Growth Drivers:

·         The necessity for personalized therapeutics for the cumulative geriatrics population and the increasing figure of diagnostics centers in both the developed and developing economies is predominant to determine profits in the global companion diagnostics market.

·         FDA had issued "Guidance for Industry: In Vitro Companion Diagnostic Devices," to assist syndicates recognize the necessity for companion diagnostics at an initial stage in the drug development procedure and to strategize for co-development of the drug and companion diagnostic test.

 On July 15, 2016, FDA introduced the draft regulation, "Principles for Co-development of an In Vitro Companion Diagnostic Device with a Therapeutic Product." This guidance text is envisioned to be a practical guide to support therapeutic product promoters and IVD sponsors in evolving a therapeutic product and an associated IVD companion diagnostic. The scientific progressions in the in-situ hybridization and automated silver-enhanced in-situ hybridization (SISH) for the monitoring of genes is trending in the global companion diagnostics market.

Schedule a Call

 Companion Diagnostic Market Players Perspective:

Some of the key players influencing the global market are:-  Abbott Laboratories, Agilent Technologies, biomerieux, Bio-Genex Laboratories, Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., QIAGEN N.V., R-Biopharm AG, and Roche Diagnostics.

In April 2017, Abbott acquired Alere for a new price of about $5.3 billion. Alere is the global leader in point of care diagnostics focused on the areas of infectious disease, molecular, cardiometabolic and toxicology. The collective business will offer the biggest point of care menu of infectious disease, molecular, cardiometabolic and toxicology testing. Abbott's platforms will be expanded to comprise benchtop and rapid strip tests.

Buy Now

 Companion Diagnostic Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the companion diagnostic market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various diagnostics in companion diagnostic market, and their specific advantages.

[wellnessweb]

Strategic Partnerships and Collaborations in the Molecular Diagnostics Market

The Molecular Diagnostics Market valued at USD 14.60 billion in 2023 and is estimated to reach USD 29.67 billion by 2032 with a CAGR of 8.22% over the forecast period 2024-2032.The molecular diagnostics market has rapidly evolved into a cornerstone of modern healthcare, where precision meets innovation.

As technology advances, molecular diagnostics harnesses the power of genetic insights to revolutionize disease detection and treatment. From identifying genetic mutations that predispose individuals to certain cancers to enabling targeted therapies based on personalized genetic profiles, this field continues to expand its impact. With its ability to deliver rapid, accurate, and actionable results, molecular diagnostics not only enhances clinical decision-making but also drives forward the era of personalized medicine, promising better outcomes and improved quality of life for patients worldwide.

The Molecular Diagnostics Market  research report offers in-depth information on anticipated trends, market drivers, development opportunities, and market restraints that may have an impact on the sector's market dynamics. Along with product, application, and competition research, it also includes in-depth analyses of several market segments. Significant actors, important alliances, mergers, and acquisitions are all examined in the study, along with current innovation and corporate strategy. This market study includes recent developments, untapped markets, new products, and investments. This report provides in-depth data on potential emerging areas as well as a market penetration analysis of well-established categories.

Get Sample Copy Of This Report @ https://www.snsinsider.com/sample-request/2806

Market Segmentation

By Product

Instruments

Reagents

Others

By Technology

Polymerase chain reaction (PCR)

PCR, by Type

Multiplex PCR

Other PCR

PCR, by Product

Instruments

Reagents

Others

In Situ Hybridization (ISH)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Chips and Microarrays

Mass Spectrometry

Transcription Mediated Amplification (TMA)

Others

Competitive Scenario

The following are the main competitors in the global Molecular Diagnostics Market  that are examined in this report along with their capacities and recent developments such as investments, mergers, and acquisitions. The study also includes a SWOT analysis and a complete industry analysis based on Porter's five forces model. It contrasts the strategies employed by different market participants to outperform rivals and boost earnings.

Key Objectives of Market Research Report

The report is stuffed with helpful information, including market trends and business opportunities for the near future.

Recent advances, strategies, and big player shares are present in the competitive environment.

Information on important market segments and sub-segments for keyword, including quantitative, qualitative, value, and volume data.

Data on supply and demand forces and their impacts on the market can be accessed at the regional, sub-regional, and national levels.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Flash Chromatography Market Size

Cystic Fibrosis Market Size

Cancer Biopsy Market Size

Glaucoma Therapeutics Market Size

Genomics Services Market Size

[vaiswr]

In Situ Hybridization Market Size Worth USD 28.86 Billion in 2030

The global in-situ hybridization market size was USD 14.32 Billion in 2021 and is expected to register a revenue CAGR of 8.14% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer, genetic disorders, and infectious diseases is a crucial factor driving market revenue growth.

In-situ hybridization is used for localization of nucleic acids and specific genes in cells, tissues, and histological sections. A reporter molecule, either fluorophore or chromophore, is linked to complementary strand of nucleic acid region of concern to visualize deoxyribonucleic or ribonucleic acids.

[diigo123456]

IHC and IHS Slide Staining Systems Market is expected to offer significant growth at a CAGR of 6.5% during the forecast period 2023-2030 | Biocare Medical, BioGenex Laboratories, Celerus Diagnostics

The market for IHC and IHS (Immunohistochemistry and In Situ Hybridization) slide staining systems is expected to grow because of improvements in healthcare and the introduction of karyotyping and other tools in disease diagnosis. With these devices, automated staining can be done quickly, more efficiently, and with higher quality. This makes each test more productive. The global market for IHC and IHS slide staining systems is divided by type, application, and region. The market is split into four different types: systems, accessories, reagents, and consumables. By use, the immunohistochemistry and in situ hybridization slide staining system market is split into drug manufacturing, pathology research, and disease detection.Estimates and forecasts of the IHC and IHS Slide Staining Systems market size are given in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the years 2017 through 2030, with 2022 as the base year. 

Click Here For A Free Sample PDF Copy Of The IHC and IHS Slide Staining Systems Market Latest Research Before Purchase:

[market-researchm]

Global In Situ Hybridization (ISH) Market Analysis, Share, Growth, Industry Trends, Overview And Forecast To 2025

Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.

It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region.

Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.

Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample

The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years.

The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.

End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.

Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.

The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Access Full Research Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market

[globalmarketsresearchreports]

Global Tissue Diagnostic Market Highlights and Forecasts to 2031

Tissue Diagnostic Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

TBRC’s market report includes a chapter on the COVID-19 impact on the tissue diagnostic industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected tissue diagnostic market growth numbers from 2022-2031.

Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp

The global tissue diagnostic market size is expected to grow from $4.27 billion in 2021 to $4.56 billion in 2022 at a compound annual growth rate (CAGR) of 6.84%. The global tissue diagnostics market share is expected to grow to $5.99 billion in 2026 at a CAGR of 7.05%.

View more on the report:

The Tissue Diagnostic Global Market Report 2022-31 by The Business Research Company evaluates tissue diagnostic market size, growth rate, drivers, tissue diagnostic industry trends, and major companies.

The tissue diagnostic market segments in the report are:

1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing System

2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining

3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)

4) By End-User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations

The table of contents in TBRC’s tissue diagnostic market report includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 28+ countries globally.  

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Information:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/

[industry-reports-data]

Companion Diagnostics Market Share, Size Global Regional Analysis, Key Findings,Industry Demand, Key Players and Forecasts to 2027

Companion Diagnostics Market research report covers inclusive data on prevalent trends, drivers, growth opportunities, and restraints that can variation the market changing aspects of the global industry. This report provides an in-depth analysis of the market segmentation that contains products, applications, and geographical analysis. Global Companion Diagnostics market report delivers a close watch on leading participants with strategic analysis, micro and macro market trend and scenarios, pricing analysis, and a complete overview of the industry conditions during the forecast period.

Report Coverage:

The research report of the defending coatings industry offers a inclusive analysis of existing companies that can affect the market outlook throughout the forthcoming years. In addition to that, it affords an accurate assessment by highlighting data on multiple aspects that may contain growth drivers, opportunities, trends, and hindrances. It also represents the overall: Companion Diagnostics market size from a global perception by analysing historical data and qualitative insights.

Companion Diagnostics Market is envisaged to record an expansion at the CAGR of 20.5% over the forecast period, 2022 – 2027.

Strong expertise with attention to detail makes our market research reports stand apart, Request a Report Sample PDF here:

Major Players Operating in the: Companion Diagnostics Market:

Tocagen, Takeda Pharmaceutical Co Ltd (TYO: 4502), Siemens Healthineers (ETR: SHL), Abbott Laboratories (NYSE: ABT), QIAGEN N.V. (NYSE: QGEN), Roche Diagnostics, Thermo Fisher Scientific Inc., Covance, Myriad Genetics Inc. (NASDAQ: MYGN), Agilent Technologies (NYSE: A), Illumina (NASDAQ: ILMN)

Companion Diagnostics Market Analysis:

The Companion Diagnostics market research report provides an in-depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. The segmentation chapters enable readers to understand aspects of the market such as its products, market size, manufacturer details, share, available technology, and applications. The research report also provides detailed information on new trends that may define the development of these segments in the coming years.

On the basis of types, the: Companion Diagnostics market is primarily split into

Polymerase Chain Reaction Test (PCR)

Immunohistochemistry Test (IHC)

In Situ Hybridization Test (ISH)

Others

On the basis of applications, the: Companion Diagnostics market covers:

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Melanoma

Others

For More Information or Query or Customization Before Buying, Visit @

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in Companion Diagnostics market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in Companion Diagnostics market.

Considering the Geographical Landscape of Companion Diagnostics market:

Companion Diagnostics Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.

➤ North America (United States, Canada, and Mexico)

➤ Europe (UK, Germany, France, Russia, and Italy)

➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)

➤ South America (Brazil, Colombia, Argentina, etc.)

➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

Research Methodology:

This report offers actionable growth insights and an extensive report comprising secondary research, primary interviews with industry stakeholders, competitors, validation, and triangulation with the Worldwide Market Reports regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.

Key Benefits for: Companion Diagnostics Market Reports:

✦ What is the global sales value, production value, consumption value, import, and export of industry?

✦ Who are the global key manufacturers of Companion Diagnostics industry? What is their operating situation?

✦ What are Companion Diagnostics market opportunities and threats faced by the vendors in the global Companion Diagnostics Industry?

✦ Which application/end-user or product type may seek incremental growth prospects?

✦ What focused approach and constraints are holding the market?

✦ What are the different sales, marketing, and distribution channels in the global industry?

About Us:

IndustryDataAnalytics is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resources, automobile, IT, technology and media, food and beverages, and consumer goods, among others.

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need

Head of Sales: Mr. Hon Irfan Tamboli

 +1 (704) 266-3234 | contact@industrydataanalytics.com

[vprprajakta]

Theranostics Market Analysis | Size, Share, Global Demand and Industry Forecast 2027

Market Overview

The overall theranostics market is driven by progress of innovative companion expressive tests. These components have helped shape the theranostics market and should uphold the turn of events. Associations in the theranostics market could in like manner stand up to challenges like shortfall of fittingly portrayed rules and lacking reimbursement workplaces. The nuances covered in the theranostics market report cover all of the pieces of the business. theranostics market examiners have also shared improvement projections in the report and have proposed theranostics market players to similarly design advancement techniques.

Market Segmentation

The overall theranostics market Has been isolated considering helpful district, advancement, and end-clients. In view of supportive district, the market for theranostics is divided considering cardiovascular diseases, immunological issues, neurological issues, oncology, and others. Additionally, the market in view of advancement, is partitioned into immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, polymerase chain reaction (PCR). The overall market for theranostics is moreover canvassed considering the end-clients segment which is also separated into indicative exploration places, clinical centers and offices, and others.

Factors like increasing paces of diligent ailments and rise in the geriatric people support the theranostics market turn of events. The introduction of theranostics market has moreover been perused up for the past and current years. Additionally, the theranostics market report gives assessment of these bits. The theranostics market segmental examination gave in the report offers huge bits of knowledge concerning the theranostics market show and future.

Key Players

Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Hoffmann-La Roche Ltd, Focus Diagnostics, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Abbott Laboratories, Myriad Genetics, Inc., Foundation Medicine, Inc., AmeriPath, Inc.

Get More Professional and Technical Industry Insights @ https://valuepropresearch.com/report/theranostics-market-1114/

Regional Overview

Associations in the theranostics market are spread across the world. The theranostics market report gives critical information about regional business areas of North America, Europe, Asia-Pacific (APAC), and the rest of the world. The North American theranostics market has numerous associations across the United States, Canada, and Mexico. Europe has associations in the theranostics market across Germany, France, Spain, Italy, and the United Kingdom. An organized assessment of the theranostics market across India, China, and Japan in the Asia-Pacific area is moreover presented in the report. The theranostics market of the Middle East, Africa, and various regions has also been concentrated by specialists. The commonplace assessment of the theranostics market can be found in the factual reviewing report.

Vicious Landscape

The theranostics market is maintained by growing combinations and acquisitions by undeniable market players. The general population advancement all around the planet and growing solicitation of theranostics market based organizations and things moreover support the market improvement. Nevertheless, the theranostics market improvement can be affected as a result of negative methodologies. The report covers commonly such nuances which will help associations in the theranostics market to invigorate their attractive procedure and further foster their thing portfolio. The theranostics market investigation report similarly gives association profiles of huge associations. The association profiles of various affiliations working in the theranostics market report highlights critical nuances like association size, pay advancement, and nuances of solidifications and acquisitions happening in the theranostics market. New associations and spread out associations can plan their techniques taking into account this data gave in the theranostics market investigation report.

Industry News

Blue Earth Diagnostics Gains induction to Scintomics' Radiohybrid's Clinical Applications Expanded cardiology stage gives a wide association in prostate sickness to decide patient therapy from across scope of clinical benefits. The showing framework on the exhibited driving position of Blue Earth Diagnostics in the successful conspicuous verification and commercialisation of radioisotopes for PET. Theranostic radiopharmaceuticals give possible use across both clinical imaging as well as prostate related treatment for harmful development.

[vaiswr]

In-Situ Hybridization Market Analysis By Industry Share, New Investment Opportunities, and Forecast till 2030

The global in-situ hybridization market size was USD 14.32 Billion in 2021 and is expected to register a revenue CAGR of 8.14% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer, genetic disorders, and infectious diseases is a crucial factor driving market revenue growth.

In-situ hybridization is used for localization of nucleic acids and specific genes in cells, tissues, and histological sections. A reporter molecule, either fluorophore or chromophore, is linked to complementary strand of nucleic acid region of concern to visualize deoxyribonucleic or ribonucleic acids. It is extensively used for assessing degree of gene expression, evaluate production of different proteins that may lead to diseases, and also diagnose pathogenic diseases based on complementary molecules of bacterial and viral genomes. In addition, applications of in-situ hybridization in karyotyping, phylogenetic analysis, physical mapping, developmental biology and pathology profiling have increased its adoption in various end-use industries and research sectors. This is expected to significantly contribute to revenue growth of the in-situ hybridization market between 2022 and 2030.

[emergenresearch1]

The global in-situ hybridization market size reached USD 905.3 Million in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, genetic disorders, and infectious diseases is expected to drive revenue growth of the global in-situ hybridization market during the forecast period.

[mrfrblogresearch02]

Theranostics Market 2022 SWOT Analysis, Key Business Strategies, Leading Industry Players, Regional Growth, Demand, Share, Challenges, Opportunities and 2027 Forecast Research Report

Market Highlights:

The global theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period. Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized medicine technology. Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment. Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases. In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.

Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules. Theranostics Market is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.

Segmentation:

The global theranostics market has been segmented into the therapeutic area, technology, end user, and region.

By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others. The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.

On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others. The sequencing segment is likely to register comparatively higher CAGR over the forecast period due to the increasing number of proof-of-concept case studies and research related to sequencing, particularly next-generation sequencing (NGS) technology.

Based on end user, the market has been classified into hospitals and clinics, diagnostic laboratories, and others.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8057

Key Players:

Few of the prominent players in the global theranostics market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Focus Diagnostics, Abbott Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Myriad Genetics, Inc., Foundation Medicine, Inc., and AmeriPath, Inc.

Regional Analysis:

The global theranostics market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would command the market throughout the forecast period attributed to the domicile of major market participants, increasing research and development activities, and growing adoption of theranostics in the US and Canada. For instance, in June 2018, Genome Canada launched a national initiative for clinical implementation of precision health that would ultimately impact the market growth in the near future.

Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and medical device companies, increasing partnerships and collaborations between life science companies and medical diagnostics companies, and growing personalized medicine sector. Personalized medicine (PM) is an emerging approach to prevention, diagnosis, treatment, and care which is assisting in addressing the challenge of the aging of the population, rising prevalence of chronic diseases, and increasing healthcare costs.

The market in Asia-Pacific would register the fastest market growth over next seven years owing to booming medical tourism, swiftly developing healthcare infrastructure, and growing awareness in the developing countries, namely, India, China, Singapore, and Australia.

The Middle East & Africa has the least share of the global theranostics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/theranostics-market-8057

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[skyquestt]

Companion Diagnostics Market Growth, Industry Outlook & Opportunities | • F. Hoffmann-La Roche AG,Agilent Technologies, Inc.

The Companion Diagnostics market was valued at USD 3.7 billion in 2020, and it is expected to reach a value of USD 13.4 billion by 2027, at a CAGR of 12.90% over the forecast period (2022 – 2027).

The market growth is mainly because of the increase in different variants of cancer among the people. As more number of clinical trials are taking place and as the demand for next generation sequencing is high, the growth of the companion diagnostic market will also remain high. Another factor which propels such a growth is the importance of the products of this market in developing various kinds of drugs.

Get FREE sample @ https://skyquestt.com/sample-request/companion-diagnostics-market

Global Companion Diagnostics Market Segmentation

The Global Companion Diagnostics market is segmented based on Product and service, Technology, Indication, End use, and Region. Based on Product and service it is categorized into: Assay kits & Reagents, Software & Services. Based on Technology it is categorized into: Polymerase Chain Reaction (PCR) , In Situ Hybridization (ISH) , Next-Generation Sequencing (NGS), Immunohistochemistry (IHC) , Others (Multiplex Assay and Cellular Imaging Technologies). Based on Indication it is categorized into: Cardiovascular, Neurological Diseases, Breast Cancer , Lung Cancer , Colorectal Cancer , Melanoma , Gastric Cancer , Infectious Diseases , Others . Based on End use it is categorized into: Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Others . Based on region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.

Key players in Companion Diagnostics market are:

F. Hoffmann-La Roche AG

Agilent Technologies, Inc.

Abbott Laboratories, Inc.

QIAGEN N.V.

Danaher Corporation

Almac Group

Thermo Fisher Scientific Inc.

BioMérieux SA

Myriad Genetics, Inc.

Scope of the Report

The study provides an analysis of the Global Companion Diagnostics Market in the emerging and established markets across the globe, including North America, Europe, Asia-Pacific, South America, and Middle East & Africa. For each segment, the market sizing and forecasts have been done on the basis of value.

Key Questions addressed in this report

Which are the high-growth market segments in terms of different segment names?

What is the historical market size for the Global Companion Diagnostics Market?

What are the market forecasts and estimates for the period 2020-2027?

What are the major drivers, restraints, opportunities, and challenges in the Global Companion Diagnostics Market?

Who are the major players in the market, and what share of the market do they hold?

Who are the major players in various countries, and what share of the market do they hold?

How is the competitive landscape for the Global Companion Diagnostics Market?

What are the recent developments in the Global Companion Diagnostics Market?

What are the different strategies adopted by the major players in the market?

What are the key geographic trends, and which are the high-growth countries?

Who are the local emerging players in the Global Companion Diagnostics Market, and

how do they compete with the other players?

Speak To Analyst@

https://skyquestt.com/speak-with-analyst/companion-diagnostics-market

Table Of Content Companion Diagnostics Market1.      Introduction2.      Research Methodology3.      Executive Summary4.      Market Overview5.      Porter’s Five Forces Analysis6.      PESTEL Analysis7.      Impact of COVID 19 on the market8.      Key Mandates & Regulations9.      Pricing Analysis10.  Competitive Analysis11.  Global Companion Diagnostics Market Value by Region and Country12.  Value by Product and service13.  Global Companion Diagnostics Market Value by Technology14.  Global Companion Diagnostics Market Value by Indication15.  Global Companion Diagnostics Market Value by End use16.  Companion Diagnostics Top Players Company ProfilesGlobal Companion Diagnostics Market: Impact of COVID 19

The market was negatively impacted due to Covid-19 in the first quarter of 2020. Tier 1 and Tier 2 companies in the market have their supply chains across the globe and were affected due to the lockdowns. Suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. The lockdown and restrictions related to social distancing implemented in these COVID-19 countries had negatively affected the supply chain of these products..

Global Companion Diagnostics Market: Regional Dynamics

In terms of the regional dynamics, the region of North America emerged to be the dominant one, this was because USA remained the major contributor to the market. This cane be attributed to the fact that USA is currently witnessing a rising cases of cancer among its population. Given the rise of cancer patients, growing research funding and investments, awareness among people regarding personalised therapies etc shows that Asia pacific will grow positively from 2020-2027.

About Us-

SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.

Contact Us-

SkyQuest Technology Consulting Pvt. Ltd.

info@skyquestt.com

USA (+1) 617-230-0741